Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Todd A. Koch"'
Publikováno v:
Haematologica, Vol 101, Iss 1 (2016)
Externí odkaz:
https://doaj.org/article/c294340744614701a7fa3038b66f2098
Publikováno v:
Anemia, Vol 2015 (2015)
Objective. To provide clinicians with evidence-based guidance for iron therapy dosing in patients with iron deficiency anemia (IDA), we conducted a study examining the benefits of a higher cumulative dose of intravenous (IV) iron than what is typical
Externí odkaz:
https://doaj.org/article/c861ab85f11d47a1a46757c87ebcae06
Publikováno v:
Anemia, Vol 2013 (2013)
Several intravenous iron complexes are available for the treatment of iron deficiency anemia (IDA). Iron dextran (DEX) is associated with an elevated risk of potentially serious anaphylactic reactions, whereas others must be administered in several s
Externí odkaz:
https://doaj.org/article/3036d86128514b1cbea6f7823496a425
Autor:
Laura L. Williamson, Stacey L. Anderson, Magdalena Kendall Scott, Todd M. Koch, Todd S. Harwell, Greg S. Holzman, Helen F Tesfai, James S. Murphy
Publikováno v:
Morbidity and Mortality Weekly Report
Geographic differences in infectious disease mortality rates have been observed among American Indian or Alaska Native (AI/AN) persons in the United States (1), and aggregate analyses of data from selected U.S. states indicate that COVID-19 incidence
This study sought to compare efficacy and safety of ferric carboxymaltose vs. placebo in iron-deficient patients with fibromyalgia. This blinded, placebo-controlled, phase 2 study randomized adults with fibromyalgia and Revised Fibromyalgia Impact Qu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60ef3acb4fe1a3f5674b6ab65cbbec6
https://europepmc.org/articles/PMC5935608/
https://europepmc.org/articles/PMC5935608/
Publikováno v:
Journal of Bone and Mineral Research. 28:1793-1803
Fibroblast growth factor 23 (FGF23) is an osteocyte-derived hormone that regulates phosphate and vitamin D homeostasis. Through unknown mechanisms, certain intravenous iron preparations induce acute, reversible increases in circulating FGF23 levels t
Publikováno v:
Anemia, Vol 2013 (2013)
Anemia
Anemia
Several intravenous iron complexes are available for the treatment of iron deficiency anemia (IDA). Iron dextran (DEX) is associated with an elevated risk of potentially serious anaphylactic reactions, whereas others must be administered in several s
Autor:
David B. Bregman, Chaim Charytan, Todd A. Koch, Angelia Butcher, David Morris, Marializa V. Bernardo
Publikováno v:
Nephrology Dialysis Transplantation. 28:953-964
Background Currently available intravenous (IV) iron agents vary in indication, dosing regimens and safety profiles. Ferric carboxymaltose (FCM) is a stable, non-dextran-containing iron formulation developed for rapid IV administration in high doses
Publikováno v:
The American Journal of Medicine. 130:991.e1-991.e8
Oral iron-replacement therapy is the mainstay of treatment for iron-deficiency anemia, but it is often poorly tolerated or ineffective. Hemoglobin response at day 14 of oral iron may be useful in assessing whether and when to transition patients from
Publikováno v:
Perceptual and Motor Skills. 89:607-625
Clinical and epidemiological studies have supported the belief that human beings exposed to stressful life events are vulnerable to the symptomatology consistent with posttraumatic stress disorder (PTSD). However, early detection of symptoms consiste